DE2560238C2 - Verfahren zur Herstellung von Desacyl-pepsidin - Google Patents
Verfahren zur Herstellung von Desacyl-pepsidinInfo
- Publication number
- DE2560238C2 DE2560238C2 DE2560238A DE2560238A DE2560238C2 DE 2560238 C2 DE2560238 C2 DE 2560238C2 DE 2560238 A DE2560238 A DE 2560238A DE 2560238 A DE2560238 A DE 2560238A DE 2560238 C2 DE2560238 C2 DE 2560238C2
- Authority
- DE
- Germany
- Prior art keywords
- pepsidin
- pepsidine
- deacyl
- ifo
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title claims description 10
- 238000002360 preparation method Methods 0.000 title claims 2
- 230000004151 fermentation Effects 0.000 claims description 9
- 238000000855 fermentation Methods 0.000 claims description 8
- 244000005700 microbiome Species 0.000 claims description 5
- WKYBEGDEGRCZNF-LBTYKNIQSA-N (3s,4s)-4-[[(2s)-2-[[(3s,4s)-4-[[(2s)-2-[[(2s)-2-acetamido-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxy-6-methylheptanoyl]amino]propanoyl]amino]-3-hydroxy-6-methylheptanoic acid Chemical compound OC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(C)=O)C(C)C WKYBEGDEGRCZNF-LBTYKNIQSA-N 0.000 claims description 4
- 241000194103 Bacillus pumilus Species 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 229940079919 digestives enzyme preparation Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 102000057297 Pepsin A Human genes 0.000 description 4
- 108090000284 Pepsin A Proteins 0.000 description 4
- 229940111202 pepsin Drugs 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000005018 casein Substances 0.000 description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 3
- 235000021240 caseins Nutrition 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 241000186361 Actinobacteria <class> Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- QNPQJKICJQEMBY-DAOOESDTSA-N Pepsinostreptin Chemical compound OC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)C(C)C)C(C)C QNPQJKICJQEMBY-DAOOESDTSA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002467 anti-pepsin effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Crystallography & Structural Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP49138862A JPS5167791A (en) | 1974-12-05 | 1974-12-05 | Desuashiruu oyobi desuashirubariruupepushijinno seizoho narabini saiashirukaho |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2560238C2 true DE2560238C2 (de) | 1984-07-19 |
Family
ID=15231860
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2560238A Expired DE2560238C2 (de) | 1974-12-05 | 1975-12-04 | Verfahren zur Herstellung von Desacyl-pepsidin |
| DE2554636A Expired DE2554636C2 (de) | 1974-12-05 | 1975-12-04 | Desacyl-pepsidin, Verfahren zu seiner Herstellung und Arzneimittel |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2554636A Expired DE2554636C2 (de) | 1974-12-05 | 1975-12-04 | Desacyl-pepsidin, Verfahren zu seiner Herstellung und Arzneimittel |
Country Status (8)
| Country | Link |
|---|---|
| JP (1) | JPS5167791A (enExample) |
| CA (1) | CA1053167A (enExample) |
| CH (1) | CH620244A5 (enExample) |
| DE (2) | DE2560238C2 (enExample) |
| FR (1) | FR2293215A1 (enExample) |
| GB (1) | GB1530921A (enExample) |
| NL (1) | NL7514241A (enExample) |
| SE (1) | SE423710B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4091093A (en) * | 1975-09-12 | 1978-05-23 | Sumitomo Chemical Company Limited | Protease inhibitors |
| JPS56164153A (en) * | 1980-05-20 | 1981-12-17 | Eisai Co Ltd | Novel desacylvalypepsidin derivative and its preparation |
| JPS56164152A (en) * | 1980-05-20 | 1981-12-17 | Eisai Co Ltd | Novel desacylpepsidin derivative and its preparation |
| JPS57189651U (enExample) * | 1981-05-27 | 1982-12-01 | ||
| JPS5956948A (ja) * | 1982-09-28 | 1984-04-02 | Nippon Kokan Kk <Nkk> | 水平連続鋳造機用モ−ルド |
| JPS60213347A (ja) * | 1984-04-06 | 1985-10-25 | Kawasaki Heavy Ind Ltd | 連続鋳造用鋳片引抜き装置 |
-
1974
- 1974-12-05 JP JP49138862A patent/JPS5167791A/ja active Granted
-
1975
- 1975-12-04 DE DE2560238A patent/DE2560238C2/de not_active Expired
- 1975-12-04 SE SE7513671A patent/SE423710B/xx not_active IP Right Cessation
- 1975-12-04 CH CH1581875A patent/CH620244A5/de not_active IP Right Cessation
- 1975-12-04 FR FR7537098A patent/FR2293215A1/fr active Granted
- 1975-12-04 DE DE2554636A patent/DE2554636C2/de not_active Expired
- 1975-12-05 CA CA241,153A patent/CA1053167A/en not_active Expired
- 1975-12-05 GB GB49988/75A patent/GB1530921A/en not_active Expired
- 1975-12-05 NL NL7514241A patent/NL7514241A/xx not_active Application Discontinuation
Non-Patent Citations (1)
| Title |
|---|
| NICHTS-ERMITTELT * |
Also Published As
| Publication number | Publication date |
|---|---|
| DE2554636C2 (de) | 1983-02-17 |
| FR2293215A1 (fr) | 1976-07-02 |
| SE7513671L (sv) | 1976-06-08 |
| CH620244A5 (en) | 1980-11-14 |
| NL7514241A (nl) | 1976-06-09 |
| CA1053167A (en) | 1979-04-24 |
| SE423710B (sv) | 1982-05-24 |
| GB1530921A (en) | 1978-11-01 |
| JPS5167791A (en) | 1976-06-11 |
| DE2554636A1 (de) | 1976-06-10 |
| JPS5339514B2 (enExample) | 1978-10-21 |
| FR2293215B1 (enExample) | 1978-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH638194A5 (de) | Esterastin, eine neue physiologisch wirksame substanz und deren herstellung. | |
| DE3006216A1 (de) | Neue verbindung monacolin k, verfahren zu ihrer herstellung und diese verbindung enthaltende arzneimittel | |
| DE2754326C2 (de) | Antibiotikum AM 2282, seine Herstellung und Arzneimittel | |
| EP0362520B1 (de) | Ein neues Antibiotikum, Mersacidin, ein Verfahren zur seiner Herstellung und seine Verwendung als Arzneimittel | |
| DE1919837C3 (de) | Leupeptine, deren Salze und Verfahren zu ihrer Herstellung | |
| DE2554636C2 (de) | Desacyl-pepsidin, Verfahren zu seiner Herstellung und Arzneimittel | |
| DE2120930A1 (de) | Pepsin-Inhibitor und Verfahren zu dessen Herstellung | |
| DE3048421C2 (de) | Antibiotische Substanz, Verfahren zu deren Herstellung und antimykotisches Mittel, welches diese enthält | |
| DE2640420C2 (de) | Als Procidine bezeichnete Peptide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Mittel | |
| DE3247175A1 (de) | Dihydro- und tetrahydromonacolin l, ihre metallsalze und alkylester sowie verfahren zu ihrer herstellung und sie enthaltende arzneimittel | |
| DE3014434A1 (de) | Antibiotikum, verfahren zu seiner herstellung und es enthaltendes arzneimittel | |
| DE2931792C2 (enExample) | ||
| DE2528984B2 (de) | Bestatin, dessen Verwendung und Verfahren zu dessen Herstellung | |
| DE3523082A1 (de) | Verfahren zur herstellung von 2-(substituylphenyl)-propionsaeure durch mikroorganismen | |
| DE2646734C3 (de) | Verfahren zur Herstellung von L-Leupeptinen | |
| DE3881812T2 (de) | Physiologisch aktive Substanzen, Probestin und Prostatin und deren Herstellung. | |
| DE2813507C3 (de) | Amastatine, Verfahren zu ihrer Gewinnung und diese enthaltende pharmazeutische Zubereitungen | |
| DE2506601B2 (de) | Tetrapeptide und Verfahren zu ihrer Herstellung | |
| DE3882654T2 (de) | Enzymhemmer und Methode zu dessen Herstellung. | |
| DE926271C (de) | Verfahren zur Gewinnung eines neuen Antibiotikums | |
| DE1070176B (de) | Verfahren zur Herstellung neuer Steroidverbindungen der 1, 4 - Pregnadienreihe | |
| DE2938993A1 (de) | Herbicolin, verfahren zu seiner herstellung und es enthaltende mittel | |
| AT381710B (de) | Verfahren zur herstellung eines neuen macrolid-antibiotikums | |
| DE2213674C3 (de) | Gemisch aus Pepstatin B und Pepstatin C, Verfahren zu dessen Herstellung und dieses Gemisch enthaltende Arzneimittel | |
| DE2316965A1 (de) | Proteaseinhibitoren, ihre herstellung und verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OI | Miscellaneous see part 1 | ||
| OI | Miscellaneous see part 1 | ||
| 8126 | Change of the secondary classification | ||
| 8181 | Inventor (new situation) |
Free format text: KUWANA, NORIAKI, INUYAMA, AICHI, JP HASEGAWA, YOSHIKAZU, FUJIGAOKA, AICHI, JP NOZU, YUKIO, KAWASHIMA, HAJIMA, JP |
|
| 8110 | Request for examination paragraph 44 | ||
| AC | Divided out of |
Ref country code: DE Ref document number: 2554636 Format of ref document f/p: P |
|
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |